Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13348660 | 0.82 | DHFR (0.31) | MAP4K4DHFR | |
| SCHEMBL13348651 | 0.69 | DHFR (0.32) | MAP4K4DHFR | |
| SCHEMBL1725141 | 0.69 | RAB9A (0.44) | — | |
| SCHEMBL13348655 | 0.67 | MAP4K4 (0.48) | MAP4K4 | |
| SCHEMBL25256571 | 0.65 | NQO2 (0.32) | — | |
| SCHEMBL31306814 | 0.65 | NQO2 (0.32) | — | |
| SCHEMBL1793376 | 0.58 | MEN1 (0.41) | — | |
| SCHEMBL3705881 | 0.58 | MMP2 (0.45) | — | |
| SCHEMBL30308911 | 0.58 | MMP2 (0.45) | — | |
| SCHEMBL27474405 | 0.57 | KDM4E (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100160346-A1 | NEUROLOGICALLY ACTIVE COMPOUNDS | PRANA BIOTECHNOLOGY LIMITED (AU) | 2010-06-24 | — | — | US | disclosed |
| US-7692011-B2 | 8-hydroxy and 8-mercapto quinazolinones | PRANA BIOTECHNOLOGY LIMITED (AU) | 2010-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160346-A1 | NEUROLOGICALLY ACTIVE COMPOUNDS | ACHE, PSEN1, PSEN2 | MAP4K4 2219/4885DHFR 1960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.